| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | $1,3450 | -1,82% | $219,39M | $262,84K | |
| $2,7850 | -0,18% | $217,47M | $158,00 | |
MFM Aberdeen Municipal Income Fund | $5,2500 | -0,38% | $217,47M | $58,57K | |
CHCI Comstock Holding Companies, Inc. Class A | $20,6950 | -1,31% | $217,46M | $4,25K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | $9,9790 | +0,39% | $217,43M | $5,91K | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | $5,6550 | -2,84% | $217,14M | $2,93K | |
EXFY Expensify, Inc. Class A Common Stock | $2,3350 | -1,48% | $217,02M | $173,30K | |
| $62,2120 | -1,24% | $216,79M | $4,52K | |
IIF Morgan Stanley India Investment Fund, Inc. | $22,6400 | -0,75% | $216,64M | $2,74K | |
VYGR Voyager Therapeutics, Inc. Common Stock | $3,2350 | -4,85% | $216,27M | $96,85K | |
MITT TPG Mortgage Investment Trust, Inc. | $6,7050 | -1,11% | $216,26M | $96,69K | |
| $1,5240 | -2,31% | $215,73M | $505,34K | |
PEPG PepGen Inc. Common Stock | $3,2750 | +2,03% | $215,39M | $445,60K | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,6150 | -1,32% | $215,12M | $188,10K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | $10,5450 | -0,05% | $214,97M | $13,00 | |
